These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Analytical determination of receptor-ligand dissociation constants of two populations of receptors from displacement curves. Almagor H; Levitzki A Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6482-6. PubMed ID: 2168549 [TBL] [Abstract][Full Text] [Related]
4. Does a radiolabelled ligand bind to a homogeneous population of non-interacting receptor sites? Swillens S; Waelbroeck M; Champeil P Trends Pharmacol Sci; 1995 May; 16(5):151-5. PubMed ID: 7624969 [TBL] [Abstract][Full Text] [Related]
5. N6-substituted N-alkyladenosine-5'-uronamides: bifunctional ligands having recognition groups for A1 and A2 adenosine receptors. Olsson RA; Kusachi S; Thompson RD; Ukena D; Padgett W; Daly JW J Med Chem; 1986 Sep; 29(9):1683-9. PubMed ID: 3018244 [TBL] [Abstract][Full Text] [Related]
6. Analysis of receptor binding displacement curves by a nonhomologous ligand, on the basis of an equivalent competition principle. van Zoelen EJ Anal Biochem; 1992 Feb; 200(2):393-9. PubMed ID: 1321566 [TBL] [Abstract][Full Text] [Related]
7. [Physico-chemical study of the heterogeneous population of opioid receptors]. Kurochkin IN; Zaĭtsev SV; Belousov AS; Skliankina OA; Varfolomeev SD Biokhimiia; 1988 Jan; 53(1):41-53. PubMed ID: 2833940 [TBL] [Abstract][Full Text] [Related]
8. Interaction of synthetic N- and C-terminal fragments of helodermin with rat liver VIP receptors. Robberecht P; Yanaihara N; Yanaihara C; De Neef P; Camus JC; Vandermeers A; Vandermeers-Piret MC; Christophe J Peptides; 1986; 7 Suppl 1():79-82. PubMed ID: 3018706 [TBL] [Abstract][Full Text] [Related]
9. Characterization of opioid binding sites in the neural and intermediate lobe of the rat pituitary gland by quantitative receptor autoradiography. Boersma CJ; Pool CW; Van Heerikhuize JJ; Van Leeuwen FW J Neuroendocrinol; 1994 Feb; 6(1):47-56. PubMed ID: 8025568 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and opioid receptor affinity of bivalent ligands derived from 3,8-diazabicyclo(3.2.1)octanes. Barlocco D; Fadda P; Fratta W Farmaco; 1993 Mar; 48(3):387-96. PubMed ID: 8391821 [TBL] [Abstract][Full Text] [Related]
12. Characterization of a guanosine-nucleotide-binding-protein-coupled receptor for pituitary adenylate-cyclase-activating polypeptide on plasma membranes from rat brain. Schäfer H; Schwarzhoff R; Creutzfeldt W; Schmidt WE Eur J Biochem; 1991 Dec; 202(3):951-8. PubMed ID: 1662620 [TBL] [Abstract][Full Text] [Related]
13. N-alkylated derivatives of [D-Pro10]dynorphin A-(1-11) are high affinity partial agonists at the cloned rat kappa-opioid receptor. Soderstrom K; Choi H; Berman FW; Aldrich JV; Murray TF Eur J Pharmacol; 1997 Nov; 338(2):191-7. PubMed ID: 9456002 [TBL] [Abstract][Full Text] [Related]
14. Determination of receptor-ligand kinetic and equilibrium binding constants using surface plasmon resonance: application to the lck SH2 domain and phosphotyrosyl peptides. Morelock MM; Ingraham RH; Betageri R; Jakes S J Med Chem; 1995 Apr; 38(8):1309-18. PubMed ID: 7537332 [TBL] [Abstract][Full Text] [Related]
15. Evidence for opiate action at the brain receptors for thyrotropin-releasing hormone. Bhargava HN; Das S Brain Res; 1986 Mar; 368(2):262-7. PubMed ID: 3008927 [TBL] [Abstract][Full Text] [Related]